• 1
    Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31: 196203.
  • 2
    Mitri G, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th/To– and anticentromere antibody–positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003; 48: 2039.
  • 3
    Okano Y, Steen VD, Medsger TA Jr. Antibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993; 119: 100513.
  • 4
    Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 3542.
  • 5
    Okano Y, Steen VD, Medsger TA Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992; 35: 95100.
  • 6
    Seraphim B. Sm and Sm-like proteins belong to a large family: identification of proteins of the U6 as well as the U1, U2, U4, and U5 snRNPs. EMBO J 1995; 14: 208998.
  • 7
    Okano Y, Medsger TA Jr. Newly identified U4/U6 snRNP-binding proteins by serum autoantibodies from a patient with systemic sclerosis. J Immunol 1991; 146: 53542.
  • 8
    Fujii T, Mimori T, Hama N, Suwa A, Akizuki M, Tojo T, et al. Characterization of autoantibodies that recognize U4/U6 small ribonucleoprotein particles in serum from a patient with primary Sjögren's syndrome. J Biol Chem 1992; 267: 164126.
  • 9
    Hashimoto C, Steitz JA. U4 and U6 RNAs coexist in a single small nuclear ribonucleoprotein particle. Nucleic Acids Res 1984; 12: 328393.
  • 10
    Okano Y, Targoff IN, Oddis CV, Fujii T, Kuwana M, Tsuzaka K, et al. Anti-U5 small nuclear ribonucleoprotein (snRNP) antibodies: a rare anti-U snRNP specificity. Clin Immunol Immunopathol 1996; 81: 417.
  • 11
    Kubo M, Ihn H, Kuwana M, Asano Y, Tamaki T, Yamane K, et al. Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap. Rheumatology (Oxford) 2002; 41: 5314.
  • 12
    Wassarman KM, Steitz JA. The low-abundance U11 and U12 small nuclear ribonucleoproteins (snRNPs) interact to form a two-snRNP complex. Mol Cell Biol 1992; 12: 127685.
  • 13
    Gilliam AC, Steitz JA. Rare scleroderma autoantibodies to the U11 small nuclear ribonucleoprotein and to the trimethyl guanosine cap of U small nuclear RNAs. Proc Natl Acad Sci USA 1993; 90: 67815.
  • 14
    Izaurralde E, Mattaj IW. Transport of RNA between nucleus and cytoplasm. Semin Cell Biol 1992; 3: 27988.
  • 15
    Okano Y, Medsger TA Jr. Novel human autoantibodies reactive with 5′-terminal trimethyl guanosine cap structures of U small nuclear RNA. J Immunol 1992; 149: 10938.
  • 16
    Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 58190.
  • 17
    Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003; 21: S604.
  • 18
    Kuwana M, Okano Y, Kaburaki J, Medsger TA Jr, Wright TM. Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. Arthritis Rheum 1999; 42: 27584.
  • 19
    Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993; 20: 18926.
  • 20
    Medsger TA Jr. Classification, prognosis. In: ClementsPJ, FurstDE, editors. Systemic sclerosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1728.